DrugPatentWatch Database Preview
Litigation Details for Encoditech LLC v. Qardio, Inc. (D. Del. 2018)
» See Plans and Pricing
Encoditech LLC v. Qardio, Inc. (D. Del. 2018)
| Docket | Start Trial | Date Filed | 2018-06-09 |
| Court | District Court, D. Delaware | Date Terminated | 2020-03-02 |
| Cause | 35:271 Patent Infringement | Assigned To | Maryellen Noreika |
| Jury Demand | Plaintiff | Referred To | |
| Patents | 10,029,011; 10,030,051; 10,041,044; 10,066,017; 10,114,012; 8,084,021; 9,109,010 | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in Encoditech LLC v. Qardio, Inc.
The biologic drugs covered by the patents cited in this case are Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , Start Trial , and Start Trial .
Details for Encoditech LLC v. Qardio, Inc. (D. Del. 2018)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-06-18 | 33 | Transcript | abstraction is divorce from the actual language of the 10:29:11 19 claim. That's the point I'm trying…asserted patent U.S. patent No. 3 9,737,803B.2 two ineligible under Section 101 of the Patent …provides patentability to, or 11:25:15 24 patentability to the claims of the '803 patent, really…#39;638 patent and claims 24 1 through 10 of the '978 patent are directed to patent 25 … is one patent at issue, United States Patent Number 02:52:42 8 9,737,803. The patent generally | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
